Seroprevalences and associated risk factors of hepatitis B and C in adults

Mustafa YILDIRIM, (Düzce Üniversitesi, Tıp Fakültesi, İnfeksiyon Hastalıkları Anabilim Dalı, Düzce, Türkiye)
Selma ÇAKIR, (Gölcük Necati Çelik Devlet Hastanesi, İnfeksiyon Hastalıkları Anabilim Dalı, Kocaeli, Türkiye)
Mehmet Faruk GEYİK, (Düzce Üniversitesi, Tıp Fakültesi, İnfeksiyon Hastalıkları Anabilim Dalı, Düzce, Türkiye)
Davut ÖZDEMİR, (Düzce Üniversitesi, Tıp Fakültesi, İnfeksiyon Hastalıkları Anabilim Dalı, Düzce, Türkiye)
Ertuğrul GÜÇLÜ, (Sakarya Eğitim ve Araştırma Hastanesi, Enfeksiyon Hastalıkları Anabilim Dalı, Sakarya, Türkiye)
Mehmet ÇAKIR (Gölcük Kavaklı İlköğretim Bakım Merkezi, Kocaeli, Türkiye)
Turkish Journal of Medical Sciences
0 0
Yıl: 2014 Cilt: 44 Sayı: 5 Sayfa Aralığı: 824 - 831 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

Seroprevalences and associated risk factors of hepatitis B and C in adults

Öz:
Background/aim: Chronic hepatitis due to hepatitis B and hepatitis C virus infections is the most common cause of chronic liver disease. In this study we aimed to find out seroprevalences and associated risk factors of hepatitis B and C in adults in Düzce. Materials and methods: The sample of study was determined with a cluster-type sampling method. The study included 1321 people, consisting of 667 women and 654 men who were 18 years or older. A questionnaire about demographic information and risk factors was applied. Results: Seroprevalences of HBsAg, anti-HBs, and anti-HCV were 4.8%, 9.4%, and 0.7%, respectively. HBsAg seroprevalences were found to be statistically higher in the dental visit group (8.9% versus 4.0%, P = 0.002) and in people living within the same house with hepatitis B carriers (11.5% versus 4.6%, P = 0.036). Living in Düzce during the 1999 earthquake and staying in prefabricated houses after the earthquake were not risk factors of HBsAg carriage. Conclusion: HBsAg and anti-HCV seroprevalences in Düzce were in parallel with the previous data from Turkey and a low ratio of antiHBs appeared. Identifying risk groups with large epidemiological screening studies and vaccination of nonimmune people are essential.
Anahtar Kelime:

Konular: Cerrahi
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Dienstag JL. Chronic viral hepatitis. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases. 7th ed. Philadelphia, PA, USA: Churchill Livingstone; 2010. pp. 1593–1617.
  • 2. Özaçar T. Hepatit B virüsü. In: Willke TA, Söyletir G, Doğanay M, editors. İnfeksiyon Hastalıkları ve Mikrobiyololjisi. 3rd ed. İstanbul, Turkey: Nobel Tıp Kitabevleri; 2008. pp. 1882–1904 (in Turkish).
  • 3. Tabak F. Viral hepatitler. In: Hamuryudan V, Öztürk R, editors. Türkiyede Sık Karşılaşılan Hastalıklar I. İstanbul, Turkey: İ.Ü. Cerrahpaşa Tıp Fakültesi Sürekli Tıp Eğitimi Etkinlikleri Dizisi; 2007. pp. 195–214 (in Turkish).
  • 4. Taşyaran MA. HBV infeksiyonu epidemiyolojisi. In: Tekeli E, Balık İ, editors. Viral Hepatit 2003. Ankara, Turkey: Viral Hepatitle Savaşım Derneği; 2003. pp. 121–128 (in Turkish).
  • 5. Ray SC, Thomas DL. Hepatitis C. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases. 7th ed. Philadelphia, PA, USA: Churchill Livingstone; 2010. pp. 2157–2185.
  • 6. Sünbül M. HCV infeksiyonunun epidemiyolojisi ve korunma. In: Tabak F, Balık İ, Tekeli E, editors. Viral Hepatit 2007. İstanbul, Turkey: Viral Hepatitle Savaşım Derneği; 2007. pp. 208–219 (in Turkish).
  • 7. Kaçar F, Erol S, Parlak M, Kadanalı A. Seroprevalence of hepatitis B virus infection in Erzurum. Infek Derg 2003; 17: 389–393 (in Turkish with an English abstract).
  • 8. Aslan G, Ulukanlıgil M, Seyrek A. Şanlıurfa’da HBsAg, AntiHBs ve Anti HCV seroprevalansı. Viral Hepatit Derg 2001; 7: 408–410 (in Turkish).
  • 9. Banak S, Yoldaşcan E, Kılıç B. The prevalence of hepatitis B surface antigen (HBsAg) and anti-hepatitis C virus (anti-HCV) in subjects of age ten and over in the semirural areas of Adana and factors affecting the prevalence. Infek Derg 2002; 16: 133– 140 (in Turkish with an English abstract).
  • 10. Kaçmaz B. Seroprevalence of hepatitis B and hepatitis C infections in Ankara city. Viral Hepatit Derg 2003; 8: 97–101 (in Turkish with an English abstract).
  • 11. Aşan A, Açar S, Çatak B, Karahasanoğlu FB, Turgut H. Evaluation of hepatitis B seroprevalence of Denizli city. Viral Hepatit Derg 2007; 12: 40–48 (in Turkish with an English abstract).
  • 12. Karabay O, Serin E, Tamer A, Gökdoğan F, Alpteker H, Ozcan A, Gündüz H. Hepatitis B carriage and Brucella seroprevalence in urban and rural areas of Bolu province of Turkey: a prospective epidemiologic study. Turk J Gastroenterol 2004; 15: 11–13.
  • 13. Delialioğlu N, Öztürk C, Aslan G. Seroprevalence of HBsAg, anti-HBs, anti-HCV and anti-HDV in Mersin. Viral Hepatit Derg 2001; 7: 416–418 (in Turkish with an English abstract).
  • 14. Dursun M, Ertem M, Yılmaz Ş, Saka G, Özekinci T, Şimşek Z. Prevalence of hepatitis B infection in the southeastern region of Turkey: comparison of risk factors for HBV infection in rural and urban areas. Jpn J Infect Dis 2005; 58: 15–19.
  • 15. Yalçın D, Yeler H, Tufan N, Gedik R. Sivas C.Ü. Diş Hekimliği Fakültesine başvuran hastalarda Hepatit B, Hepatit C sıklığının saptanması. CÜ Diş Hek Fak Derg 2001; 4: 97–101 (in Turkish with an English abstract).
  • 16. Doğru Ü. Nozokomiyal viral infeksiyonlardan korunma.. Klimik Derg 2000; 33: 32–34 (in Turkish).
  • 17. Khan H, Hayat Z, Rehman SU, Zarif M. Comparative analysis of risk factors and complications of hepatitis B and C infections at Khyber Teaching Hospital, Peshawar. Hepat Mon 2007; 7: 83–86.
  • 18. Sali S, Bashtar R, Alavian SM. Risk Factors in chronic hepatitis B infection: a case-control study. Hepat Mon 2005; 5: 109–115.
  • 19. Erden S, Büyüköztürk S, Çalangu S, Kardeş BA, Kaysı A, Yılmaz G, Badur S, Palandüz Ş. Seroprevalences of HBsAg, anti-HBs, and anti-HCV in out patients. Türk Mikrobiyol Cem Derg 2000; 30: 131–134 (in Turkish with an abstract in English).
  • 20. Wang CS, Chang TT, Yao WJ, Chou P. Comparison of hepatitis B virus and hepatitis C virus prevalence and risk factors in a community-based study. Am J Trop Med Hyg 2002; 66: 389– 393.
  • 21. Yenice N, Cansız M, Arıcan N, Gökten Y, Durgut C, Türkmen S. HBsAg and anti-HCV seroprevalence in spouses of patients with chronic hepatitis B and chronic hepatitis C. Akademik Gastroenterol Dergisi 2004; 3: 79–82 (in Turkish with an English abstract).
  • 22. Nurgalieva ZZ, Hollinger FB, Graham DY, Zhangabylova S, Zhangabylov A. Epidemiology and transmission of hepatitis B and C viruses in Kazakhstan. World J Gastroenterol 2007; 13: 1204–1207.
  • 23. Otkun M, Erdoğan MS, Tatman M, Akata F. Exposure time to hepatitis B virus and associated risk factors among children in Edirne, Turkey. Epidemiol Infect 2005; 133: 509–516.
  • 24. Khan S, Rai MA, Khan A, Farooqui A, Kazmi SU, Ali SH. Prevalence of HCV and HIV infections in 2005 earthquakeaffected areas of Pakistan. BMC Infect Dis 2008; 8: 147.
  • 25. Badur S. Hepatitis B infections: epidemiology and vaccine. Klinik Gelişim 2005; 18: 32–43 (in Turkish with an abstract in English).
  • 26. Sunanchaikarn S, Theamboonlers A, Chongsrisawat V, Yoocharoen P, Tharmaphornpilas P, Warinsathien P, Sinlaparatsamee S, Paupunwatana S, Chaiear K, Khwanjaipanich S et al. Seroepidemiology and genotypes of hepatitis C virus in Thailand. Asian Pac J Allergy Immunol 2007; 25: 175–182.
  • 27. Mishra S, Chayani N, Sarangi G, Mallick B, Pati SB. Seroprevalence of anti HCV antibody in and around Cuttack, Orissa. Indian J Med Microbiol 2002; 20: 40–41.
  • 28. Kölgeliler S, Ertek M, Erol S, Taşyaran MA. Hepatit C virus seroprevalence central and rural areas of Erzurum. Viral Hepatit Derg 2003; 8: 166–170 (in Turkish with an English abstract).
  • 29. Ağuş N, Özkalay Yılmaz N, Cengiz A, Şanal E, Sert H. HBsAg, anti-HCV and anti-HIV seroprevalence in blood donors. ANKEM 2008; 22: 7–9 (in Turkish with an English abstract).
  • 30. Kökoğlu ÖF, Geyik MF, Uçmak H, Aslan S, Ayaz C, Hoşoğlu S. The prevalence of HBsAg and anti-HCV in blood donors at Diyarbakır region. Viral Hepatit Derg 2003; 8: 56–59 (in Turkish with abstract in English).
APA yıldırım m, ÇAKIR S, GEYİK M, ÖZDEMİR D, Guclu E, Cakir M (2014). Seroprevalences and associated risk factors of hepatitis B and C in adults. , 824 - 831.
Chicago yıldırım mustafa,ÇAKIR Selma,GEYİK Mehmet Faruk,ÖZDEMİR Davut,Guclu Ertugrul,Cakir Mehmet Seroprevalences and associated risk factors of hepatitis B and C in adults. (2014): 824 - 831.
MLA yıldırım mustafa,ÇAKIR Selma,GEYİK Mehmet Faruk,ÖZDEMİR Davut,Guclu Ertugrul,Cakir Mehmet Seroprevalences and associated risk factors of hepatitis B and C in adults. , 2014, ss.824 - 831.
AMA yıldırım m,ÇAKIR S,GEYİK M,ÖZDEMİR D,Guclu E,Cakir M Seroprevalences and associated risk factors of hepatitis B and C in adults. . 2014; 824 - 831.
Vancouver yıldırım m,ÇAKIR S,GEYİK M,ÖZDEMİR D,Guclu E,Cakir M Seroprevalences and associated risk factors of hepatitis B and C in adults. . 2014; 824 - 831.
IEEE yıldırım m,ÇAKIR S,GEYİK M,ÖZDEMİR D,Guclu E,Cakir M "Seroprevalences and associated risk factors of hepatitis B and C in adults." , ss.824 - 831, 2014.
ISNAD yıldırım, mustafa vd. "Seroprevalences and associated risk factors of hepatitis B and C in adults". (2014), 824-831.
APA yıldırım m, ÇAKIR S, GEYİK M, ÖZDEMİR D, Guclu E, Cakir M (2014). Seroprevalences and associated risk factors of hepatitis B and C in adults. Turkish Journal of Medical Sciences, 44(5), 824 - 831.
Chicago yıldırım mustafa,ÇAKIR Selma,GEYİK Mehmet Faruk,ÖZDEMİR Davut,Guclu Ertugrul,Cakir Mehmet Seroprevalences and associated risk factors of hepatitis B and C in adults. Turkish Journal of Medical Sciences 44, no.5 (2014): 824 - 831.
MLA yıldırım mustafa,ÇAKIR Selma,GEYİK Mehmet Faruk,ÖZDEMİR Davut,Guclu Ertugrul,Cakir Mehmet Seroprevalences and associated risk factors of hepatitis B and C in adults. Turkish Journal of Medical Sciences, vol.44, no.5, 2014, ss.824 - 831.
AMA yıldırım m,ÇAKIR S,GEYİK M,ÖZDEMİR D,Guclu E,Cakir M Seroprevalences and associated risk factors of hepatitis B and C in adults. Turkish Journal of Medical Sciences. 2014; 44(5): 824 - 831.
Vancouver yıldırım m,ÇAKIR S,GEYİK M,ÖZDEMİR D,Guclu E,Cakir M Seroprevalences and associated risk factors of hepatitis B and C in adults. Turkish Journal of Medical Sciences. 2014; 44(5): 824 - 831.
IEEE yıldırım m,ÇAKIR S,GEYİK M,ÖZDEMİR D,Guclu E,Cakir M "Seroprevalences and associated risk factors of hepatitis B and C in adults." Turkish Journal of Medical Sciences, 44, ss.824 - 831, 2014.
ISNAD yıldırım, mustafa vd. "Seroprevalences and associated risk factors of hepatitis B and C in adults". Turkish Journal of Medical Sciences 44/5 (2014), 824-831.
Sayfa Oluşturulma Tarihi
23-04-2024 0:34

İLETİŞİM

TÜBİTAK ULAKBİM TR Dizin

Yüzüncüyıl, İşçi Blokları Mahallesi

Muhsin Yazıcıoğlu Caddesi No:51/C

06530 Çankaya / ANKARA +90 (312) 298 92 00

trdizin@tubitak.gov.tr

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © Tüm Hakları Saklıdır. Gizlilik Politikası Kullanım Şartları